Susan G. Komen Bay Area MORE THAN PINK Walk Raises Funds for Breast Cancer Research and Support
PorAinvest
martes, 2 de septiembre de 2025, 3:12 pm ET1 min de lectura
BAC--
The Bay Area MORE THAN PINK Walk will take place at the San Francisco Zoo & Gardens, with gates opening at 9:30 a.m. The event aims to unite the community and raise critical funds for Komen's mission. The funds will support Komen's investment in lifesaving research and patient care, including its Patient Care Center and the Center for Public Policy.
Breast cancer affects 1 in 8 women and 1 in 1,000 men in their lifetime, with an estimated 316,950 women and 2,800 men expected to be diagnosed in 2025 in the U.S. alone. Approximately 42,170 women and 510 men are expected to die from the disease. The event also aims to raise awareness about the importance of early detection and the need for continued research into more effective treatments.
Susan G. Komen's Patient Care Center provides direct support to California residents, including financial assistance to eligible people in active treatment or living with metastatic breast cancer. In fiscal year 2025, Komen provided assistance to 2,108 patients, including $478,400 in financial assistance.
The event is a significant opportunity for the community to come together and support those affected by breast cancer, while also advocating for increased investment in breast cancer research and patient care.
References:
[1] https://secure.info-komen.org/site/TR?company_id=112163&fr_id=10955&pg=company
[2] https://www.marketscreener.com/news/olema-oncology-announces-new-clinical-trial-agreement-with-pfizer-to-combine-palazestrant-with-atirm-ce7c50d3dc8cf423
[3] https://www.businesswire.com/news/home/20250902172298/en/Susan-G.-Komen-To-Host-MORE-THAN-PINK-Walk-in-San-Francisco-This-October
NTRA--
NVS--
Susan G. Komen will host the 2025 MORE THAN PINK Walk in San Francisco on October 5. The event aims to raise $400,000 to fund Komen's lifesaving work, including research and patient care. The walk is open to anyone who has been diagnosed with breast cancer and their support networks. Bank of America is the national presenting sponsor, with Lily, Natera, and Novartis as national series sponsors. Local sponsors include Gilead Oncology, Athleta, and Omnicell.
Susan G. Komen, the world's leading breast cancer organization, will host the 2025 MORE THAN PINK Walk in San Francisco on October 5. The event aims to raise $400,000 to fund Komen's lifesaving work, including research and patient care. The walk is open to anyone who has been diagnosed with breast cancer and their support networks. Bank of America is the national presenting sponsor, with Lily, Natera, and Novartis as national series sponsors. Local sponsors include Gilead Oncology, Athleta, and Omnicell.The Bay Area MORE THAN PINK Walk will take place at the San Francisco Zoo & Gardens, with gates opening at 9:30 a.m. The event aims to unite the community and raise critical funds for Komen's mission. The funds will support Komen's investment in lifesaving research and patient care, including its Patient Care Center and the Center for Public Policy.
Breast cancer affects 1 in 8 women and 1 in 1,000 men in their lifetime, with an estimated 316,950 women and 2,800 men expected to be diagnosed in 2025 in the U.S. alone. Approximately 42,170 women and 510 men are expected to die from the disease. The event also aims to raise awareness about the importance of early detection and the need for continued research into more effective treatments.
Susan G. Komen's Patient Care Center provides direct support to California residents, including financial assistance to eligible people in active treatment or living with metastatic breast cancer. In fiscal year 2025, Komen provided assistance to 2,108 patients, including $478,400 in financial assistance.
The event is a significant opportunity for the community to come together and support those affected by breast cancer, while also advocating for increased investment in breast cancer research and patient care.
References:
[1] https://secure.info-komen.org/site/TR?company_id=112163&fr_id=10955&pg=company
[2] https://www.marketscreener.com/news/olema-oncology-announces-new-clinical-trial-agreement-with-pfizer-to-combine-palazestrant-with-atirm-ce7c50d3dc8cf423
[3] https://www.businesswire.com/news/home/20250902172298/en/Susan-G.-Komen-To-Host-MORE-THAN-PINK-Walk-in-San-Francisco-This-October
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios